Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension
France Dierick, Julien Solinc, Juliette Bignard, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1338-1338
Open Access | Times Cited: 25

Showing 25 citing articles:

Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies
Helen Christou, Raouf A. Khalil
AJP Heart and Circulatory Physiology (2022) Vol. 322, Iss. 5, pp. H702-H724
Open Access | Times Cited: 47
Pulmonary Vascular Remodeling in Pulmonary Hypertension
Zhuangzhuang Jia, Shuai Wang, Haifeng Yan, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 366-366
Open Access | Times Cited: 31
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca2+ signaling
Angela Balistrieri, Ayako Makino, Jason X.‐J. Yuan
Physiological Reviews (2022) Vol. 103, Iss. 3, pp. 1827-1897
Open Access | Times Cited: 29
Biology and function of pericytes in the vascular microcirculation
Yue Wu, Jiaqi Fu, Yuxia Huang, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 4, pp. 337-345
Open Access | Times Cited: 20
PROSPECTIVE SINGLE CENTER ANALYSIS OF OUTCOME STEM CELLS TRANSPLANTS IN PATIENTS WITH CEREBRAL PALSY
Nasser Ghaly Yousif, Maitham G. Yousif, Ahmed Mohsen, et al.
Polski Merkuriusz Lekarski (2023) Vol. 51, Iss. 4, pp. 339-345
Closed Access | Times Cited: 12
A predictive model for early postoperative hypoxemia after mitral valve replacement combined with pulmonary arterial hypertension
Xin Lv, Mengmeng Tang, Li Weisong, et al.
Surgery (2025) Vol. 181, pp. 109280-109280
Closed Access
Management of Pulmonary Arterial Hypertension: Current Strategies and Future Prospects
Munish Sharma, Vivek Paudyal, Saifullah Syed, et al.
Life (2025) Vol. 15, Iss. 3, pp. 430-430
Open Access
Flow Cytometric Determination of Circulating Progenitor Cells in Patients With Pulmonary Arterial Hypertension: A Systematic Review
Kimia Heydari, Carrie L. Johnson, Ian Cooper, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access
Engineering Spatiotemporal Control in Vascularized Tissues
Astha Khanna, Beu P. Oropeza, Ngan F. Huang
Bioengineering (2022) Vol. 9, Iss. 10, pp. 555-555
Open Access | Times Cited: 16
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension
Sue Gu, Khushboo Goel, Lindsay M. Forbes, et al.
Comprehensive physiology (2023), pp. 4295-4319
Open Access | Times Cited: 9
Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies
Hamza Boucetta, Lei Zhang, Alejandro Sosnik, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 236-258
Closed Access | Times Cited: 9
The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
Julien Solinc, Jonathan Ribot, Florent Soubrier, et al.
Life (2022) Vol. 12, Iss. 5, pp. 658-658
Open Access | Times Cited: 12
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension
Paul D. Upton, Benjamin J. Dunmore, Wei Li, et al.
Developmental Dynamics (2022) Vol. 252, Iss. 3, pp. 327-342
Open Access | Times Cited: 8
Unlocking the Future: Pluripotent Stem Cell-Based Lung Repair
Tobias Goecke, F. Ius, Arjang Ruhparwar, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 635-635
Open Access | Times Cited: 1
Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue
Zhendong Zhong, Kang Li, Chongyang Shen, et al.
Human Cell (2023) Vol. 37, Iss. 1, pp. 214-228
Closed Access | Times Cited: 2
Selective Loading and Variations in the miRNA Profile of Extracellular Vesicles from Endothelial-like Cells Cultivated under Normoxia and Hypoxia
Anny Waloski Robert, Bruna Hilzendeger Marcon, Addeli Bez Batti Angulski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10066-10066
Open Access | Times Cited: 4
New Insight into Molecular and Hormonal Connection in Andrology
Davide Francomano, Valerio Sanguigni, Paolo Capogrosso, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11908-11908
Open Access | Times Cited: 5
Pulmonary Hypertension Associated with Chronic Lung Disease
Yuanchen Wang, Rodolfo A. Estrada, Khushboo Goel, et al.
Current Respiratory Medicine Reviews (2024) Vol. 20, Iss. 2, pp. 171-184
Closed Access
Diabetes-Induced Vascular Dysfunction and Stemness Decline Investigated via Transcription Factor-Driven Genetic Switches
Ovais Shafi, Saba Irfan, Aelia Ahmed, et al.
Research Square (Research Square) (2024)
Open Access
Clinical usefulness of endothelial progenitor cells in predicting the efficacy of riociguat in chronic thromboembolic pulmonary hypertension.
Ryo Imai, Shiro Adachi, Masahiro Yoshida, et al.
PubMed (2024) Vol. 86, Iss. 2, pp. 292-303
Closed Access
Navigating stem cell culture: insights, techniques, challenges, and prospects
Aleksandra Górska, Mateusz Trubalski, Bartosz Borowski, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Important Role of Endogenous Nerve Growth Factor Receptor in the Pathogenesis of Hypoxia-Induced Pulmonary Hypertension in Mice
Chiaki Goten, Soichiro Usui, Shinichiro Takashima, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1868-1868
Open Access | Times Cited: 1
Immunomodulatory macrophages and Treg in pulmonary hypertension
Ayobami Matthew Olajuyin, Adefunke Kafayat Olajuyin, X. Zhang, et al.
Comparative Clinical Pathology (2023) Vol. 33, Iss. 1, pp. 163-173
Closed Access | Times Cited: 1
Hydroxysafflower Yellow A Inhibits Vascular Adventitial Fibroblast Migration via NLRP3 Inflammasome Inhibition through Autophagy Activation
Lin Liu, Qingzhuo Cui, Junna Song, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 172-172
Open Access | Times Cited: 2
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension
Sue Gu, Khushboo Goel, Lindsay M. Forbes, et al.
Comprehensive physiology (2023) Vol. 13, Iss. 1, pp. 4295-4319
Closed Access
Page 1

Scroll to top